The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025889

Enrollment

Unknown

Registered

2019-09-12

Start date

2019-09-30

Completion date

Unknown

Last updated

2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Experimental group:TCM tuina

Control:Observation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) clinical diagnosis of PD based on the criteria of United Kingdom Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDBB); (2) aged between 18 and 80 years old; (3) treatment with antiparkinsonian drugs (such as levodopa), stable over the previous two months; and (4) able to speak and understand Cantonese.

Exclusion criteria

Exclusion criteria: (1) Atypical or secondary parkinsonism; (2) Use of antidepressants during the preceding month; (3) History of psychosis; (4) Suicide attempts during the preceding 12 months; (5) Severe diseases (i.e. cancer, stroke and acute present heart attack); (6) Participating in other behavioural or pharmacological studies; (7) Pregnancy or beast feeding; (8) Surgery within preceding two months or having a scheduled operation within the period of study; or (9) Hoehn and Yahr (H&Y) stage ?4, with activities limited to wheelchairs.

Design outcomes

Primary

Measure	Time frame
Total score of the Non-Motor Symptom Scale (NMSS);	—

Secondary

Measure	Time frame
Total score of the Deficiency of Spleen Qi rating scale (DSQ);Total score of MDS-UPDRS;	—

Countries

China

Contacts

Public ContactProf. LI Min

CMTR, SCM, HKBU

limin@hkbu.edu.hk+852 3411 5387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026